Hester Biosciences' stock climbs 2% as poultry giant seeks to expand foot in pet care industry

22 Mar 2022 , 03:42 PM

Hester Biosciences Limited is set to venture into the emerging pet care sector this April. India is the fastest-growing pet care hub worldwide, witnessing a growth of 14% in 2022, making this an unmissable opportunity for the poultry vaccine giant.

Hester has a competitive advantage in form of cutting-edge R&D capabilities, comprehensive knowledge of animal biology, and four-decade-long experience in animal healthcare. The said expansion is in line with the company’s core beliefs and vision to provide health for human beings through healthy animals.

Its initial pet care portfolio will comprise products ranging from dermatology, anti-infective, grooming, and specialty products. The goal is to create products suitable for pets and their varied needs.

Hester seeks eventual expansion by way of pet biologicals and diagnostics. The complete portfolio will focus on both veterinarians and pet parents with offerings that cater to the evolving needs of pets.

Company’s pet care project is scheduled to be live in April 2022.

Hester Biosciences ended at Rs2,492.70 up by Rs22.8 or 0.92% from its previous closing of Rs2,469.90 on the BSE. It touched intraday high and low of Rs2,559.90 and Rs2,457.05 respectively.